Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KPC-type beta-lactamases are a group of class A serine beta-lactamase enzymes that confer resistance to a broad spectrum of beta-lactam antibiotics, including penicillins, cephalosporins, monobactams, and especially carbapenems. These enzymes are most commonly found in Enterobacteriaceae such as Klebsiella pneumoniae, but have also been detected in other Gram-negative bacteria. The bla_KPC gene is plasmid-mediated, facilitating rapid horizontal gene transfer. Multiple allelic variants exist (notably KPC-2 and KPC-3), contributing to substrate specificity and inhibitor resistance. KPC enzymes are major contributors to multidrug resistance among Gram-negative pathogens.
Hydrolyzes the beta-lactam ring of antibiotics, rendering them ineffective.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Klebsiella pneumoniae carbapenemase.